Wellington Management Group
JAZZ icon

Wellington Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wellington Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-520
Closed -$809K – 2256
2017
Q4 		$809K Sell
520
-46
-8% -$6.38K ﹤0.01% 1946
2017
Q3 		$580K Buy
566
+366
+183% +$55.4K ﹤0.01% 2010
2017
Q2 		$221K Buy
+200
New +$30.6K ﹤0.01% 2157

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wellington Management Group's JAZZ Position: Q2 2026 in Review

Wellington Management Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 61% in Q2 2026, selling an estimated $61.1M and leaving 179,141 shares worth $43.2M. The position accounts for 0.01% of the portfolio, ranked #794.

Wellington Management Group first reported a position in JAZZ in Q2 2013 and has held it in 49 quarters since. The position peaked at $409M in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wellington Management Group held 179,141 shares of Jazz Pharmaceuticals worth $43.2M as of Q2 2026.
  • Wellington Management Group sold 278,873 Jazz Pharmaceuticals shares in Q2 2026, an estimated $61.1M.
  • Jazz Pharmaceuticals made up 0.01% of Wellington Management Group's portfolio in Q2 2026, its #794 holding.
  • Wellington Management Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Wellington Management Group's Jazz Pharmaceuticals position peaked at $409M in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.